Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7975059 | 0.85 | — | — | |
| SCHEMBL302529 | 0.82 | — | — | |
| SCHEMBL272208 | 0.79 | — | — | |
| SCHEMBL28612695 | 0.79 | — | — | |
| SCHEMBL105383 | 0.75 | — | — | |
| SCHEMBL24453458 | 0.75 | — | — | |
| SCHEMBL721893 | 0.75 | LMNA (0.58) | — | |
| SCHEMBL6035995 | 0.75 | MAPK1 (0.35) | MAPK1 | |
| SCHEMBL3312764 | 0.75 | — | — | |
| SCHEMBL20223616 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023222559-A1 | PROCESS FOR PREPARING DEUTERATED ORGANIC COMPOUNDS | MERCK PATENT GMBH (DE) | 2023-11-23 | — | — | WO | disclosed |
| US-20220411361-A1 | CARBONATE CONTAINING LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | ARES CAPITAL CORPORATION, AS AGENT | 2022-12-29 | — | — | US | disclosed |
| US-9988340-B2 | Compositions and methods for the treatment of multiple sclerosis | CELLIX BIO PRIVATE LIMITED (IN) | 2018-06-05 | — | — | US | disclosed |
| US-9932294-B2 | Compositions and methods for the treatment of multiple sclerosis | CELLIX BIO PRIVATE LIMITED (IN) | 2018-04-03 | — | — | US | disclosed |
| US-9771355-B2 | Compositions and methods for the treatment of epilepsy and neurological disorders | CELLIX BIO PRIVATE LIMITED (IN) | 2017-09-26 | — | — | US | disclosed |
| US-9765020-B2 | Dichlorophenyl-imino compounds and compositions, and methods for the treatment of mucositis | CELLIX BIO PRIVATE LIMITED (IN) | 2017-09-19 | — | — | US | disclosed |
| US-9738631-B2 | Compositions and methods for the treatment of neurological disorders | CELLIX BIO PRIVATE LIMITED (IN) | 2017-08-22 | — | — | US | disclosed |
| US-9642915-B2 | Compositions and methods for the treatment of neuromuscular disorders and neurodegenerative diseases | CELLIX BIO PRIVATE LIMITED (IN) | 2017-05-09 | — | — | US | disclosed |
| US-9624168-B2 | Compositions and methods for the treatment inflammation and lipid disorders | CELLIX BIO PRIVATE LIMITED (IN) | 2017-04-18 | — | — | US | disclosed |
| US-9604920-B2 | Compositions and methods for the treatment of hyperglycemia and metabolic syndrome | ALAPATI MOHAN MURALI (IN) | 2017-03-28 | — | — | US | disclosed |
| EP-1059279-B1 | Polyvinyl ether compound and method of preperation | IDEMITSU KOSAN CO (JP) | 2005-08-17 | — | — | EP | disclosed |
| US-20040106808-A1 | Processes for preparing calanolide a and intermediates thereof | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 2004-06-03 | — | — | US | disclosed |
| EP-1352907-A1 | PROCESSES FOR PREPARING CALANOLIDE A AND INTERMEDIATES THEREOF | KURARAY CO., LTD. (JP) | 2003-10-15 | — | — | EP | disclosed |
| EP-1059279-A1 | Polyvinyl ether compound and method of preperation | IDEMITSU KOSAN CO., LTD. (JP) | 2000-12-13 | — | — | EP | disclosed |
| EP-0644175-B1 | POLYVINYL ETHER COMPOUND AND LUBRICATING OIL | IDEMITSU KOSAN CO (JP) | 1999-10-20 | — | — | EP | disclosed |
| US-5616812-A | POLYMERIZING VINYL ETHER IN THE PRESENCE OF CATALYST AND SPECIFIC ACETAL | IDEMITSU KOSAN CO., LTD. (JP) | 1997-04-01 | — | — | US | disclosed |
| US-5589597-A | HYDROGENATION | IDEMITSU KOSAN CO., LTD. (JP) | 1996-12-31 | — | — | US | disclosed |
| US-5523491-A | REACTING ACETAL OR KETAL COMPOUND WITH HYDROGEN IN PRESENCE OF HYDROGENATION AND SOLID ACID CATALYSTS | IDEMITSU KOSAN CO., LTD. (JP) | 1996-06-04 | — | — | US | disclosed |
| EP-0644175-A1 | POLYVINYL ETHER COMPOUND AND LUBRICATING OIL | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1995-03-22 | — | — | EP | disclosed |
| US-5399631-A | Polyvinyl ether compound | IDEMITSU KOSAN CO., LTD. (JP) | 1995-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040106808-A1 | Processes for preparing calanolide a and intermediates thereof | CALR, CYP51A1, CYP4A11 | ALDH1A1 1043/4885TSHR 3981/4885TDP1 4180/4885 |
| US-20220411361-A1 | CARBONATE CONTAINING LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS | PHOSPHO1, LNPK, SGMS1 | ALDH1A1 4788/4885TSHR 3052/4885TDP1 4267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.